Trial Profile
EHOA: Etanercept as treatment for Hand OsteoArthritis A randomized, double-blind, placebo-controlled trial to evaluate the clinical efficacy and the structure modifying properties of etanercept 50/25 mg subcutaneous weekly in patients with eroive osteoarthritis of the interphalangeal finger joints.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Aug 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms EHOA
- 10 Aug 2011 New trial record